KEYS vs PTGX · P/E 57, rev $5.16B vs rev $269.8M
Keysight Technologies Inc (KEYS) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the KEYS and PTGX stock pages for the full models.
Not investment advice.